We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Raman Technique Visualizes Details Almost to a Trillionth of a Meter

By Biotechdaily staff writers
Posted on 05 May 2008
A team of researchers has developed a new type of imaging system that can illuminate tumors in living subjects--obtaining images with a precision of nearly one-trillionth of a meter. More...


This technique, called Raman spectroscopy, expands the existing range of tools for the field of molecular imaging, according to team leader Sanjiv Sam Gambhir, M.D., Ph.D., professor of radiology at Stanford University School of Medicine (Stanford, CA, USA). He is the senior author of a study describing the application that was published in the March 31, 2008, advance online issue of the journal Proceedings of the [U.S.] National Academy of Sciences (PNAS).

"This is an entirely new way of imaging living subjects, not based on anything previously used,” said Dr. Gambhir, who directs the Molecular Imaging Program at Stanford. He reported that signals from Raman spectroscopy are stronger and longer lived than other available techniques, and the type of particles used in this method can transmit information about multiple types of molecular targets simultaneously. "Usually we can measure one or two things at a time,” he said. "With this, we can now likely see 10, 20, 30 things at once.

Dr. Gambhir reported that he believes this is the first time Raman spectroscopy has been used to image deep within the body, using tiny nanoparticles injected into the body to serve as beacons. When laser light is beamed from a source outside the body, these specialized particles emit signals that can be measured and translated into a visible indicator of their location in the body.

Postdoctoral scholars Shay Keren, Ph.D., and Cristina Zavaleta, Ph.D., co-first authors of the study, found a way to make Raman spectroscopy a medical application. To accomplish this, they used two types of engineered Raman nanoparticles: gold nanoparticles and single-wall carbon nanotubes. First, they injected mice with the some of the nanoparticles. To see the nanoparticles, they used a special microscope that the group had adapted to view anesthetized mice exposed to laser light. The researchers could see that the nanoparticles migrated to the liver, where they were processed for excretion.

To be able to detect molecular events, according to Dr. Zavaleta, they labeled separate batches of spectrally unique Raman nanoparticles with different "tags” (peptides or antibodies) and then injected them into the body simultaneously to see where they went. For example, if each type of particle migrated to a different tumor site, the newly developed Raman microscope would enable the researchers to separate the signals from each batch of particles.

As part of this proof-of-principle work, Dr. Gambhir's team tagged the gold nanoparticles with different bits of proteins that homed in on different tumor molecules. "We could attach pretty much anything,” said Dr. Gambhir. The Raman effect also lasts indefinitely, so the particles do not lose effectiveness as indicators as long as they stay in the body.

Using a microscope they modified to detect Raman nanoparticles, the researchers were able to visualize targets on a scale 1,000 times smaller than what is now obtainable by the most precise fluorescence imaging using quantum dots. When modified for human use, they researchers reported, the technique has the potential to be useful during surgery, for example, in the removal of cancerous tissue. The extreme sensitivity of the imager could enable detection of even the smalltest malignant tissues.

A clinical trial is planned to test the gold nanoparticles in humans for possible use in conjunction with a colonoscopy to indicate early-stage colorectal cancer.


Related Links:
Stanford University School of Medicine

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
hCG Whole Blood Pregnancy Test
VEDALAB hCG-CHECK-1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.